Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

BACKGROUND: Natural products may provide a source for the discovery and development of adjunctive pharmacological interventions to modulate the inflammatory pathways contributing to chronic disease. Xanthohumol, a flavonoid from the hops plant (Humulus lupulus), has antioxidant and anti-inflammatory...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Bradley, Ryan, Langley, Blake O., Ryan, Jennifer J., Phipps, John, Hanes, Douglas A., Stack, Emily, Jansson, Janet K., Metz, Thomas O., Stevens, Jan Frederik
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7542976/
https://ncbi.nlm.nih.gov/pubmed/33028396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04769-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky